4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-17-065657
Options or other derivatives
- EVP, Chief Financial Officer acquired 72,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bell Graeme · EVP, Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-12-12 | Grant or award : show line 1 in the form Stock Option (right to buy) | +72,500 | 72,500 | D |
Loading xslF345X03/doc4.xml…